Clinical trials
Active, not recruiting Immune System Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 7 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| UNC Lineberger Comprehensive Cancer Center | 6 |
| Bristol-Myers Squibb | 2 |
| Center for International Blood and Marrow Transplant Research | 2 |
| National Cancer Institute (NCI) | 2 |
| Viatris Innovation GmbH | 2 |
| Alumis Inc | 1 |
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| Aravax Pty Ltd | 1 |
| AstraZeneca | 1 |
| Beeline Medicines Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 26 |
| Autoimmune Diseases | 11 |
| Lymphoproliferative Disorders | 9 |
| Immunoproliferative Disorders | 8 |
| Lymphatic Diseases | 7 |
| Lymphoma | 7 |
| Neoplasms | 7 |
| Connective Tissue Diseases | 6 |
| Lupus Erythematosus, Systemic | 6 |
| Neoplasms by Histologic Type | 5 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.